S&P 500   3,616.01 (-0.61%)
DOW   29,571.98 (-1.13%)
QQQ   298.63 (-0.13%)
AAPL   119.94 (+2.87%)
MSFT   212.44 (-1.30%)
FB   274.38 (-1.23%)
GOOGL   1,754.85 (-1.80%)
AMZN   3,170.43 (-0.78%)
TSLA   581.89 (-0.66%)
NVDA   529.59 (-0.16%)
BABA   264.86 (-4.20%)
CGC   29.16 (+0.55%)
GE   10.28 (-1.15%)
MU   64.44 (+0.33%)
AMD   92.06 (+5.59%)
T   28.81 (-0.76%)
NIO   51.45 (-4.72%)
F   9.09 (+0.00%)
ACB   11.74 (+12.13%)
NFLX   488.11 (-0.66%)
BA   213.09 (-1.58%)
GILD   59.94 (-0.15%)
DIS   147.68 (+0.37%)
S&P 500   3,616.01 (-0.61%)
DOW   29,571.98 (-1.13%)
QQQ   298.63 (-0.13%)
AAPL   119.94 (+2.87%)
MSFT   212.44 (-1.30%)
FB   274.38 (-1.23%)
GOOGL   1,754.85 (-1.80%)
AMZN   3,170.43 (-0.78%)
TSLA   581.89 (-0.66%)
NVDA   529.59 (-0.16%)
BABA   264.86 (-4.20%)
CGC   29.16 (+0.55%)
GE   10.28 (-1.15%)
MU   64.44 (+0.33%)
AMD   92.06 (+5.59%)
T   28.81 (-0.76%)
NIO   51.45 (-4.72%)
F   9.09 (+0.00%)
ACB   11.74 (+12.13%)
NFLX   488.11 (-0.66%)
BA   213.09 (-1.58%)
GILD   59.94 (-0.15%)
DIS   147.68 (+0.37%)
S&P 500   3,616.01 (-0.61%)
DOW   29,571.98 (-1.13%)
QQQ   298.63 (-0.13%)
AAPL   119.94 (+2.87%)
MSFT   212.44 (-1.30%)
FB   274.38 (-1.23%)
GOOGL   1,754.85 (-1.80%)
AMZN   3,170.43 (-0.78%)
TSLA   581.89 (-0.66%)
NVDA   529.59 (-0.16%)
BABA   264.86 (-4.20%)
CGC   29.16 (+0.55%)
GE   10.28 (-1.15%)
MU   64.44 (+0.33%)
AMD   92.06 (+5.59%)
T   28.81 (-0.76%)
NIO   51.45 (-4.72%)
F   9.09 (+0.00%)
ACB   11.74 (+12.13%)
NFLX   488.11 (-0.66%)
BA   213.09 (-1.58%)
GILD   59.94 (-0.15%)
DIS   147.68 (+0.37%)
S&P 500   3,616.01 (-0.61%)
DOW   29,571.98 (-1.13%)
QQQ   298.63 (-0.13%)
AAPL   119.94 (+2.87%)
MSFT   212.44 (-1.30%)
FB   274.38 (-1.23%)
GOOGL   1,754.85 (-1.80%)
AMZN   3,170.43 (-0.78%)
TSLA   581.89 (-0.66%)
NVDA   529.59 (-0.16%)
BABA   264.86 (-4.20%)
CGC   29.16 (+0.55%)
GE   10.28 (-1.15%)
MU   64.44 (+0.33%)
AMD   92.06 (+5.59%)
T   28.81 (-0.76%)
NIO   51.45 (-4.72%)
F   9.09 (+0.00%)
ACB   11.74 (+12.13%)
NFLX   488.11 (-0.66%)
BA   213.09 (-1.58%)
GILD   59.94 (-0.15%)
DIS   147.68 (+0.37%)
Log in
NYSE:TMO

Thermo Fisher Scientific Stock Forecast, Price & News

$463.65
+10.25 (+2.26 %)
(As of 11/30/2020 02:15 PM ET)
Add
Compare
Today's Range
$453.40
Now: $463.65
$464.73
50-Day Range
$439.56
MA: $475.01
$527.66
52-Week Range
$250.21
Now: $463.65
$532.57
Volume60,334 shs
Average Volume1.68 million shs
Market Capitalization$183.76 billion
P/E Ratio50.18
Dividend Yield0.19%
Beta0.98
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrödinger, Inc. to expand structure-based drug discovery to novel targets using Cryo-EM; an agreement with Daiichi Sankyo; and collaboration with Northeastern University. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.
Read More
Thermo Fisher Scientific logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 3.6Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.12 out of 5 stars


Industry, Sector and Symbol

Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryLife Sciences Tools & Services
SectorMedical
CUSIP88355610
Phone781-622-1000
Employees75,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$25.54 billion
Cash Flow$18.18 per share
Book Value$74.00 per share

Profitability

Net Income$3.70 billion

Miscellaneous

Market Cap$183.76 billion
Next Earnings Date2/4/2021 (Estimated)
OptionableOptionable
$463.65
+10.25 (+2.26 %)
(As of 11/30/2020 02:15 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TMO News and Ratings via Email

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Thermo Fisher Scientific (NYSE:TMO) Frequently Asked Questions

How has Thermo Fisher Scientific's stock been impacted by COVID-19?

Thermo Fisher Scientific's stock was trading at $289.38 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TMO shares have increased by 60.1% and is now trading at $463.31.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Thermo Fisher Scientific?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last year. There are currently 3 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Thermo Fisher Scientific
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Thermo Fisher Scientific?

Wall Street analysts have given Thermo Fisher Scientific a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Thermo Fisher Scientific wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Thermo Fisher Scientific's next earnings date?

Thermo Fisher Scientific is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for Thermo Fisher Scientific
.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc. (NYSE:TMO) released its quarterly earnings data on Wednesday, October, 21st. The medical research company reported $5.63 earnings per share for the quarter, beating analysts' consensus estimates of $4.37 by $1.26. The medical research company earned $8.25 billion during the quarter, compared to analyst estimates of $7.68 billion. Thermo Fisher Scientific had a net margin of 14.12% and a return on equity of 18.18%. Thermo Fisher Scientific's revenue was up 31.6% compared to the same quarter last year. During the same quarter last year, the company earned $2.94 earnings per share.
View Thermo Fisher Scientific's earnings history
.

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific declared a quarterly dividend on Thursday, November 5th. Stockholders of record on Tuesday, December 15th will be given a dividend of $0.22 per share on Friday, January 15th. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.19%. The ex-dividend date is Monday, December 14th.
View Thermo Fisher Scientific's dividend history
.

How will Thermo Fisher Scientific's stock buyback program work?

Thermo Fisher Scientific declared that its board has approved a stock buyback program on Thursday, November 5th 2020, which permits the company to buyback $2,500,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 1.2% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board of directors believes its shares are undervalued.

What price target have analysts set for TMO?

17 brokerages have issued 1 year target prices for Thermo Fisher Scientific's stock. Their forecasts range from $340.00 to $550.00. On average, they expect Thermo Fisher Scientific's stock price to reach $481.13 in the next twelve months. This suggests a possible upside of 3.8% from the stock's current price.
View analysts' price targets for Thermo Fisher Scientific
.

Who are some of Thermo Fisher Scientific's key competitors?

What other stocks do shareholders of Thermo Fisher Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Thermo Fisher Scientific investors own include Johnson & Johnson (JNJ), The Home Depot (HD), NVIDIA (NVDA), Cisco Systems (CSCO), Alibaba Group (BABA), Honeywell International (HON), The Walt Disney (DIS), CVS Health (CVS), Visa (V) and The Procter & Gamble (PG).

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the following people:
  • Mr. Marc N. Casper, CEO, Pres & Chairman (Age 52, Pay $6.27M)
  • Mr. Stephen Williamson, Sr. VP & CFO (Age 53, Pay $1.74M)
  • Mr. Mark P. Stevenson, Exec. VP & COO (Age 57, Pay $2.78M)
  • Mr. Syed A. Jafry, Sr. VP & Pres of Regions (Age 56, Pay $1.26M)
  • Mr. Michel Lagarde, Exec. VP (Age 45, Pay $2.28M)
  • Mr. Peter E. Hornstra, VP & Chief Accounting Officer (Age 60)
  • Mr. Ryan J. Snyder, Sr. VP & Chief Information Officer
  • Mr. Kenneth J. Apicerno, VP of Investor Relations
  • Mr. Michael A. Boxer Esq., Sr. VP & Gen. Counsel (Age 58)
  • Ms. Sandy Pound, VP & Chief Communications Officer

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

Who are Thermo Fisher Scientific's major shareholders?

Thermo Fisher Scientific's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.29%), State Street Corp (4.11%), Massachusetts Financial Services Co. MA (3.41%), Morgan Stanley (1.87%), UBS Asset Management Americas Inc. (0.72%) and Alps Advisors Inc. (0.49%). Company insiders that own Thermo Fisher Scientific stock include C Martin Harris, Gregory J Herrema, Jim P Manzi, Marc N Casper, Mark Stevenson, Peter E Hornstra, Stephen Williamson, Syed A Jafry and Tyler Jacks.
View institutional ownership trends for Thermo Fisher Scientific
.

Which institutional investors are selling Thermo Fisher Scientific stock?

TMO stock was sold by a variety of institutional investors in the last quarter, including CIBC Private Wealth Group LLC, Massachusetts Financial Services Co. MA, Diamond Hill Capital Management Inc., State Street Corp, Veritas Asset Management LLP, Morgan Stanley, NN Investment Partners Holdings N.V., and Public Employees Retirement Association of Colorado. Company insiders that have sold Thermo Fisher Scientific company stock in the last year include Jim P Manzi, Marc N Casper, Mark Stevenson, Peter E Hornstra, Stephen Williamson, and Syed A Jafry.
View insider buying and selling activity for Thermo Fisher Scientific
.

Which institutional investors are buying Thermo Fisher Scientific stock?

TMO stock was bought by a variety of institutional investors in the last quarter, including Alps Advisors Inc., Sustainable Growth Advisers LP, AKO Capital LLP, CIBC Private Wealth Group LLC, Commerzbank Aktiengesellschaft FI, Bradley Foster & Sargent Inc. CT, Zurcher Kantonalbank Zurich Cantonalbank, and Jupiter Asset Management Ltd..
View insider buying and selling activity for Thermo Fisher Scientific
.

How do I buy shares of Thermo Fisher Scientific?

Shares of TMO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of TMO stock can currently be purchased for approximately $463.31.

How big of a company is Thermo Fisher Scientific?

Thermo Fisher Scientific has a market capitalization of $183.63 billion and generates $25.54 billion in revenue each year. The medical research company earns $3.70 billion in net income (profit) each year or $12.35 on an earnings per share basis. Thermo Fisher Scientific employs 75,000 workers across the globe.

What is Thermo Fisher Scientific's official website?

The official website for Thermo Fisher Scientific is www.thermofisher.com.

How can I contact Thermo Fisher Scientific?

Thermo Fisher Scientific's mailing address is 168 Third Avenue, Waltham MA, 02451. The medical research company can be reached via phone at 781-622-1000 or via email at [email protected]

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.